RANK as a therapeutic target in cancer

The FEBS journal

Volumn 283, Issue 11, 2016, Pages 2018-2033

  González Suárez, Eva ^a   Sanz Moreno, Adrián ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

bone metastasis and immunity; cancer therapeutics; RANK; RANKL; tumor cell intrinsic hallmarks

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; BONE REMODELING; BREAST NEOPLASMS; CELL DIFFERENTIATION; EPITHELIUM CELL; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MAMMARY GLAND; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; SIGNAL TRANSDUCTION;

BONE REMODELING; BREAST NEOPLASMS; CELL DIFFERENTIATION; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MOLECULAR TARGETED THERAPY; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84989815392     PISSN: None     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13645     Document Type: Review

References (0)